Use of Urinary Bladder Matrix, a Bioactive, Acellular Scaffold, in Transplant Donor Scars and Androgenetic Alopecia: Initial Clinical Experience
March 2012
in “The American Journal of Cosmetic Surgery”
TLDR UBM helps hair regrowth in men and women with hair loss.
The document reports on a series of case studies that used urinary bladder matrix (UBM) to facilitate hair regrowth in both donor scar areas and in areas of hair loss in both men and women. The results suggest that UBM technology is a useful tool in restoration therapy in men and women with androgenetic hair loss. The study found that UBM stimulated more follicles to grow than merely the one that was transplanted, suggesting that UBM may facilitate hair regrowth in androgenetic hair loss. Although more studies are necessary to further understand the role of UBM in folliculogenesis, the initial results are promising.
View this study on journals.sagepub.com →
Cited in this study
research Extracellular Matrix Degradation Products and Low-Oxygen Conditions Enhance the Regenerative Potential of Perivascular Stem Cells
Low-oxygen conditions and ECM degradation products increase the healing abilities of perivascular stem cells.
research Bioengineering the Hair Follicle
Bioengineering can potentially treat hair loss by regenerating hair follicles and cloning hair, but the process is complex and needs more research.
research Long-term renewal of hair follicles from clonogenic multipotent stem cells
Adult stem cells from rat whisker follicles can regenerate hair follicles and sebaceous glands.
research Organogenesis From Dissociated Cells: Generation of Mature Cycling Hair Follicles From Skin-Derived Cells
Scientists have found a way to create hair follicles from skin cells of newborn mice, which can grow and cycle naturally when injected into adult mouse skin.
research Androgenetic alopecia: An autosomal dominant disorder
Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.
research Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex
Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.
Related
research Sisaipho Alopecia Areata Treated With Tofacitinib and Oral Minoxidil
Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.
research Progenitor‐cell‐enriched micrografts as a novel option for the management of androgenetic alopecia
Micrografts promote hair growth in androgenetic alopecia treatment.
research Body to scalp: Evolving trends in body hair transplantation
Body hair transplants can treat baldness but differ from scalp hair and need more research on long-term results and side effects.
research Regenerative medicine and hair loss: how hair follicle culture has advanced our understanding of treatment options for androgenetic alopecia
Hair follicle culture helps develop new treatments for hair loss.
research Hair Follicle Transplantation on Scar Tissue
Hair follicle transplantation can hide scars but often needs more than one surgery for better results.
research The Latest Innovations in Hair Transplantation
New hair transplant methods offer more natural results and better graft survival, with ongoing research to increase donor hair options.
research Hair transplantation for the treatment of post-irradiation alopecia
Hair transplant is effective for treating hair loss caused by radiation and improves patients' quality of life.